152 related articles for article (PubMed ID: 31165237)
21. Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China.
Yue Y; Yang H; Wu K; Yang L; Chen J; Huang X; Pan Y; Ruan Y; Zhao Y; Shi X; Sun Q; Li Q
PLoS One; 2013; 8(1):e55204. PubMed ID: 23372836
[TBL] [Abstract][Full Text] [Related]
22. E6 and E7 Gene Polymorphisms in Human Papillomavirus Types-58 and 33 Identified in Southwest China.
Chen Z; Jing Y; Wen Q; Ding X; Wang T; Mu X; Chenzhang Y; Cao M
PLoS One; 2017; 12(1):e0171140. PubMed ID: 28141822
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.
Pande S; Jain N; Prusty BK; Bhambhani S; Gupta S; Sharma R; Batra S; Das BC
J Clin Microbiol; 2008 Mar; 46(3):1060-6. PubMed ID: 18199779
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic Human Papillomavirus Infection and Genotype Characterization among Women in Orodara, Western Burkina Faso.
Traore IMA; Zohoncon TM; Ndo O; Djigma FW; Obiri-Yeboah D; Compaore TR; Guigma SP; Yonli AT; Traore G; Ouedraogo P; Ouedraogo CMR; Traore Y; Simpore J
Pak J Biol Sci; 2016; 19(7):306-311. PubMed ID: 29023032
[TBL] [Abstract][Full Text] [Related]
25. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
26. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
27. Molecular variants of HPV-16 associated with cervical cancer in Indian population.
Pillai MR; Hariharan R; Babu JM; Lakshmi S; Chiplunkar SV; Patkar M; Tongaonkar H; Dinshaw K; Jayshree RS; Reddy BK; Siddiqui M; Roychoudury S; Saha B; Abraham P; Gnanamony M; Peedicayil A; Subhashini J; Ram TS; Dey B; Sharma C; Jain SK; Singh N
Int J Cancer; 2009 Jul; 125(1):91-103. PubMed ID: 19358280
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus (HPV) 18 genetic variants and cervical cancer risk in Taizhou area, China.
Xu HH; Zheng LZ; Lin AF; Dong SS; Chai ZY; Yan WH
Gene; 2018 Mar; 647():192-197. PubMed ID: 29331480
[TBL] [Abstract][Full Text] [Related]
29. L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis.
Chen Z; Jing Y; Wen Q; Ding X; Zhang S; Wang T; Zhang Y; Zhang J
Virol J; 2016 Oct; 13(1):167. PubMed ID: 27717385
[TBL] [Abstract][Full Text] [Related]
30. [Prediction of B cell epitopes of human papillomavirus type 16 L1 protein].
Wang A; Jiang M; Li N; Zhang G; Qi Y; Liu Y; Xi Y; Zhou J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):442-5. PubMed ID: 27053606
[TBL] [Abstract][Full Text] [Related]
31. HPV16 L1 diversity and its potential impact on the vaccination-induced immunity.
El Aliani A; El Abid H; Kassal Y; Khyatti M; Attaleb M; Ennaji MM; El Mzibri M
Gene; 2020 Jul; 747():144682. PubMed ID: 32304786
[TBL] [Abstract][Full Text] [Related]
32. Type-specific detection of 30 oncogenic human papillomaviruses by genotyping both E6 and L1 genes.
Peng J; Gao L; Guo J; Wang T; Wang L; Yao Q; Zhu H; Jin Q
J Clin Microbiol; 2013 Feb; 51(2):402-8. PubMed ID: 23152557
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands.
de Boer MA; Peters LA; Aziz MF; Siregar B; Cornain S; Vrede MA; Jordanova ES; Kolkman-Uljee S; Fleuren GJ
Gynecol Oncol; 2004 Aug; 94(2):488-94. PubMed ID: 15297193
[TBL] [Abstract][Full Text] [Related]
34. Phylogeny and In Silico Structure Analysis of Major Capsid Protein (L1) Human Papillomavirus 45 from Indonesian Isolates.
Pradini GW; Sahiratmadja E; Suhandono S; Sudigdoadi S; Yusuf M; Firdaus ARR; Susanto H
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2517-2523. PubMed ID: 32986347
[TBL] [Abstract][Full Text] [Related]
35. [Human Papilloma virus in Quechua women from Jujuy with high frequency of cervical cancer: viral types and HPV-16 variants].
Picconi MA; Gronda J; Alonio LV; Villa LL; Sichero L; Miranda S; Barcena M; Teyssie A
Medicina (B Aires); 2002; 62(3):209-20. PubMed ID: 12150002
[TBL] [Abstract][Full Text] [Related]
36. Genetic variability in minor capsid protein (L2 gene) of human papillomavirus type 16 among Indian women.
Mane A; Limaye S; Patil L; Kulkarni-Kale U
Med Microbiol Immunol; 2022 Jun; 211(2-3):153-160. PubMed ID: 35552511
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.
Balanda M; Quiero A; Vergara N; Espinoza G; Martín HS; Rojas G; Ramírez E
Med Microbiol Immunol; 2016 Dec; 205(6):585-594. PubMed ID: 27539577
[TBL] [Abstract][Full Text] [Related]
38. The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy.
Guan J; Bywaters SM; Brendle SA; Lee H; Ashley RE; Christensen ND; Hafenstein S
J Virol; 2015 Dec; 89(23):12108-17. PubMed ID: 26401038
[TBL] [Abstract][Full Text] [Related]
39. Identification of human papillomavirus-16 E6 variation in cervical cancer and their impact on T and B cell epitopes.
Kumar A; Hussain S; Yadav IS; Gissmann L; Natarajan K; Das BC; Bharadwaj M
J Virol Methods; 2015 Jun; 218():51-8. PubMed ID: 25800725
[TBL] [Abstract][Full Text] [Related]
40. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
